Galectin 3 for the diagnosis of bladder cancer

OBJECTIVE: To evaluate serum levels of galectin-3 (G-3) in patients with bladder cancer and a control group, as a potential diagnostic and prognostic serum tumour marker. PATIENTS AND METHODS: Between November 2012 and January 2013, 55 patients (median age 58 years) were enrolled into three groups,...

Descripción completa

Detalles Bibliográficos
Autores principales: El Gendy, Hoda, Madkour, Bothina, Abdelaty, Sara, Essawy, Fayza, Khattab, Dina, Hammam, Olfat, El Kholy, Amr, Nour, Hani H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2014
Materias:
Uroscience Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4434779/
https://www.ncbi.nlm.nih.gov/pubmed/26019945
http://dx.doi.org/10.1016/j.aju.2013.10.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4434779/
https://www.ncbi.nlm.nih.gov/pubmed/26019945
http://dx.doi.org/10.1016/j.aju.2013.10.004

Ejemplares similares